This map shows the geographic impact of W. Vater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Vater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Vater more than expected).
This network shows the impact of papers produced by W. Vater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Vater. The network helps show where W. Vater may publish in the future.
Co-authorship network of co-authors of W. Vater
This figure shows the co-authorship network connecting the top 25 collaborators of W. Vater.
A scholar is included among the top collaborators of W. Vater based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W. Vater. W. Vater is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Meyer, H., F. BOSSERT, E Wehinger, K. Stoepel, & W. Vater. (1981). [Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions (author's transl)].. PubMed. 31(3). 407–9.12 indexed citations
Kazda, S., B Garthoff, H. Meyer, et al.. (1980). Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).. PubMed. 30(12). 2144–62.108 indexed citations
BOSSERT, F., et al.. (1979). [The influence of the ester function on the vasodilating activity of 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-pyridine-3,5-dicarboxylates (author's transl)].. PubMed. 29(2). 226–9.6 indexed citations
8.
Vater, W., G. Kroneberg, F Hoffmeister, et al.. (1972). 4-(2’-ニトロフェニル)-2,6-ジメチル-1,4-ジヒドロビリジン-3,5-ジカルボン酸ジメチルエステル(ニフェジピン),BAY-a-1040の薬理作用. 22(1). 1–14.51 indexed citations
9.
Vater, W., G. Kroneberg, F Hoffmeister, et al.. (1972). [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].. PubMed. 22(1). 1–14.71 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.